Results for prophylactic translation from English to Maltese

prophylactic antibiotics
antibijotiċi profilattiċi

dose adjustments for prophylactic dose ranges
aġġustamenti tad-doża għal firxiet tad-doża profilattika

prophylactic antipyretic medication is recommended:
52 mediċina profilattika kontra d- deni hi rakkomandata:

prophylactic administration of folic acid is recommended.
l-għoti profilattiku ta’ aċidu foliku hi rakkomandat.

prophylactic treatment with corticosteroids should be considered.
kura profilattika b’kortikosterojdi għandha tiġi kkunsidrata.

animal blood prepared for therapeutic or prophylactic uses
demm tal-annimali ppreparat għal użu terapewtiku jew profilattiku

this directive does not affect prophylactic vaccination policies.
din id-direttiva ma tolqotx il-politika ta' tilqim profilattiku.

dose adjustments for prophylactic dose ranges of enoxaparin sodium
aġġustamenti tad-doża għal firxiet tad-doża profilattika ta' enoxaparin sodium

prophylactic efficacy in women with current or prior infection
effikaċja profilattika f’ nisa b’ infezzjoni kurrenti jew fil- passat.

prophylactic treatment for diarrhoea should be administered as indicated.
kura profilattika għal dijarea għandha tingħata kif indikat.

prophylactic anti-emetic medicinal products should be considered.
prodotti mediċinali profilattiċi anti-emetiċi għandhom jiġu kkunsidrati.

the median dose per prophylactic infusion was 37.8 iu/kg.
id-doża medjana għal kull infużjoni profilattika kienet ta’ 37.8 iu/kg.

prophylactic antibiotics should be considered particularly in patients with neutropenia.
anti-bijotiċi profilattiċi għandhom jiġu kkunsidrati partikularment f’pazjenti b’newtropenja.

limitation of prophylactic use of antimicrobials to cases with defined clinical needs;
il-limitazzjoni tal-użu profilattiku ta' antimikrobiċi għal każijiet bi ħtiġijiet kliniċi definiti;

a separate rapid-acting bronchodilator should be considered for such prophylactic use .
għal dan, għandu jiġi kkunsidrat bronkodilatur li jaħdem malajr separat.

11 table 2 undesirable effects in the prophylactic paediatric congenital heart disease clinical study
12 tabella 2 effetti mhux mixtieqa fi studju kliniku profilattiku f’ pazjenti pedjatriċi b’ mard tal- qalb konġenitali

other medicaments for therapeutic or prophylactic uses, of hs 3003, n.p.r.s.
duwa oħrajn għal użi terapewtiċi jew profilattiċi ta hs 30.03, n.p.r.s.

in clinical studies, patients received prophylactic acetylsalicylic acid or alternative anti-thrombotic therapy.
fi studji kliniċi, il-pazjenti rċivew acetylsalicylic acid profilattiku jew terapija antitrombotika jew terapija alternattiva.

prophylactic efficacy against hpv-16/18 infection in a population naïve to oncogenic hpv types
effikaċja profilattika kontra infezzjoni b’hpv-16/18 f’popolazzjoni mingħajr esperjenza ta’ tipi hpv onkoġeniċi.

prophylactic heparin increased the risk of non-serious bleeding (see section 4.8).
eparina mgħotija bħala profilassi żdiedet ir-riskju ta’ dik il-fsada li m’hijiex serja (ara sezzjoni 4.8).